Skip to main content

Table 3 Differences in patients recruited to different study types

From: Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

     Percentage of ethnic origin
Studies Percentage with WHO class III Percentage with WHO class IV Percentage with WHO class V White Black Hispanic Other
Randomised trials 12 78 10 9 35 19 38
Cohort of lupus nephritis 7 64 29 24 11 1 63
Cohort of SLE Not appropriate 59 29 0 12
  1. SLE, systemic lupus erythematosus; WHO, World Health Organization.
\